Table 2.

Prevalence of cervical cancer at AGC, HSIL, and LSIL, by age (years) at detection abnormality and histopathology of cancer

Age (years)	AGC			HSIL			LSIL
	No of cases	Prevalence (%)*		No of cases	Prevalence (%)*		No of cases	Prevalence (%)*
All histopathologies
All ages	198	1.35		1633	2.49		428	0.18
23-29	18	1.22		197	0.82		78	0.08
30-39	75	2.29		663	2.84		155	0.23
40-49	70	1.30		489	3.92		124	0.24
50-59	35	0.78		284	5.01		71	0.23
Adenocarcinoma
All ages	145	0.99		163	0.25		49	0.02
23-29	11	0.75		16	0.07		8	0.01
30-39	51	1.55		71	0.30		12	0.02
40-49	54	1.00		50	0.40		20	0.04
50-59	29	0.65		26	0.46		9	0.03
Squamous cell cancer
All ages	44	0.30		1418	2.16		368	0.15
23-29	6	0.41		173	0.72		68	0.07
30-39	20	0.61		569	2.44		141	0.21
40-49	14	0.26		429	3.44		100	0.19
50-59	4	0.09		247	4.36		59	0.19

*Percentage of prevalent cancer among women with abnormality.